Examkin

Question

Difficulty: HardPreventive Care and Screening

During a scheduled health maintenance visit, a 24-year-old male college student is evaluated. He reports feeling well and has no acute complaints. Two weeks ago, he underwent an emergency splenectomy following a severe mountain biking accident that caused massive splenic rupture. His postoperative recovery has been uncomplicated. He has no other medical conditions and takes no daily medications. He does not smoke, drink alcohol, or use illicit drugs. Review of his immunization records shows that he completed all standard childhood vaccinations, including a single dose of the quadrivalent meningococcal conjugate vaccine (MenACWY) and the tetanus, diphtheria, and acellular pertussis (Tdap) vaccine at age 11. He has not received any vaccines since that time.

Based on current Advisory Committee on Immunization Practices (ACIP) guidelines, administration of which of the following vaccine regimens is the most appropriate next step for this patient today?

  1. A
    Administer MenACWY and serogroup B meningococcal vaccines only, to target the most common post-splenectomy pathogens.
  2. B
    Administer 20-valent pneumococcal conjugate and Tdap vaccines only, as additional immunizations are not indicated.
  3. Administer 20-valent pneumococcal conjugate, MenACWY, serogroup B meningococcal, Haemophilus influenzae type b, and Tdap vaccines.Answer
  4. D
    Administer 23-valent pneumococcal polysaccharide, serogroup B meningococcal, and Haemophilus influenzae type b vaccines.
  5. E
    Defer all immunizations for at least 3 months postoperatively to allow for adequate immune system recovery.

Answer

The most appropriate approach is to administer the 20-valent pneumococcal conjugate vaccine, the MenACWY booster, the serogroup B meningococcal vaccine, the Haemophilus influenzae type b vaccine, and a Tdap booster.
Patients with anatomic or functional asplenia are at severe risk for overwhelming post-splenectomy infection (OPSI), primarily driven by encapsulated organisms: Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae type b (Hib). According to current ACIP guidelines, these patients require comprehensive vaccination against all three pathogens. For pneumococcal coverage, adults with asplenia who have not previously received a conjugate vaccine should receive a single dose of PCV20 (or alternatively, PCV15 followed by PPSV23). For meningococcal coverage, they require both the MenACWY vaccine (a booster is needed here since his initial dose was more than 5 years ago) and the initiation of the MenB vaccine series. A single dose of the Hib vaccine is also strongly indicated for asplenic adults who were not vaccinated in adulthood. Furthermore, because the patient's last Tdap was at age 11 (13 years ago), a routine 10-year booster is indicated today. Timing is critical; for emergency splenectomies, vaccines should be administered at least 14 days postoperatively to ensure an optimal immune response without unnecessarily delaying protection, making today the ideal time for administration.

Step-by-Step Solution

1
Identify the patient's immunocompromised state and the associated risk profile.
The patient is 14 days post-emergency splenectomy, resulting in anatomic asplenia. He is at severe risk for overwhelming post-splenectomy infection (OPSI) caused by encapsulated organisms.
The spleen plays a critical role in the opsonization and phagocytic clearance of encapsulated bacteria from the bloodstream.
2
Determine the optimal timing for immunization.
Vaccines should be administered today.
For emergency splenectomies, current guidelines recommend administering indicated vaccines at least 14 days postoperatively. This allows the immune system to recover sufficiently from surgical stress to mount an adequate antibody response.
3
Identify the specific pathogens that require targeted vaccination.
The patient requires protection against Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae type b.
These three pathogens are the primary encapsulated bacteria responsible for rapid, fatal sepsis in asplenic patients.
4
Select the exact vaccine formulations required by ACIP guidelines for an unimmunized adult asplenic patient.
The indicated regimen includes PCV20 (pneumococcal), MenACWY (booster, as his last dose was >5 years ago), MenB (primary series), Hib (single dose for unimmunized asplenic adults), and Tdap (routine booster, as his last dose was >10 years ago).
This combination comprehensively fulfills the 2026 evidence-based recommendations for maximizing post-splenectomy immunity.

Key Concept

Adults with anatomic or functional asplenia require targeted vaccination against encapsulated organisms (S. pneumoniae, N. meningitidis, H. influenzae) administered at least 14 days following an emergency splenectomy.
Rate this question

Topics

Preventive Care and Screening

More questions from this topic